We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Type Predisposes to Certain Viral Infections

By LabMedica International staff writers
Posted on 30 Apr 2012
Some strains of Rotavirus find their way into the cells of the gastrointestinal tract by recognizing antigens associated with the type A blood group. More...


Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.

Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.

In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.

The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.

B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.

Related Links:
Baylor College of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Platelet Function Analyzer
PL-12
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.